197 related articles for article (PubMed ID: 12579599)
1. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.
Guillevin L; Cohen P; Mahr A; Arène JP; Mouthon L; Puéchal X; Pertuiset E; Gilson B; Hamidou M; Lanoux P; Bruet A; Ruivard M; Vanhille P; Cordier JF
Arthritis Rheum; 2003 Feb; 49(1):93-100. PubMed ID: 12579599
[TBL] [Abstract][Full Text] [Related]
2. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L;
Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268
[TBL] [Abstract][Full Text] [Related]
3. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
[TBL] [Abstract][Full Text] [Related]
5. Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.
Samson M; Puéchal X; Mouthon L; Devilliers H; Cohen P; Bienvenu B; Ly KH; Bruet A; Gilson B; Ruivard M; Pertuiset E; Hamidou M; Pagnoux C; Terrier B; Guillevin L;
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):176-184. PubMed ID: 28422001
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
Pagnoux C; Seror R; Henegar C; Mahr A; Cohen P; Le Guern V; Bienvenu B; Mouthon L; Guillevin L;
Arthritis Rheum; 2010 Feb; 62(2):616-26. PubMed ID: 20112401
[TBL] [Abstract][Full Text] [Related]
7. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
Guillevin L; Lhote F; Jarrousse B; Fain O
Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
[TBL] [Abstract][Full Text] [Related]
8. Classical polyarteritis nodosa and microscopic polyangiitis--a clinicopathologic study.
Handa R; Wali JP; Gupta SD; Dinda AK; Aggarwal P; Wig N; Biswas A
J Assoc Physicians India; 2001 Mar; 49():314-9. PubMed ID: 11291968
[TBL] [Abstract][Full Text] [Related]
9. Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, Meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis.
Guillevin L; Cevallos R; Durand-Gasselin B; Lhote F; Jarrousse B; Callard P
Ann Med Interne (Paris); 1997; 148(3):198-204. PubMed ID: 9255326
[TBL] [Abstract][Full Text] [Related]
10. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.
Guillevin L; Jarrousse B; Lok C; Lhote F; Jais JP; Le Thi Huong Du D; Bussel A
J Rheumatol; 1991 Apr; 18(4):567-74. PubMed ID: 1676753
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
12. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?
Agard C; Mouthon L; Mahr A; Guillevin L
Arthritis Rheum; 2003 Oct; 49(5):709-15. PubMed ID: 14558058
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Bienvenu B; Ruivard M; Terrier B; Pagnoux C; Mouthon L; Guillevin L;
Autoimmun Rev; 2014 Feb; 13(2):197-205. PubMed ID: 24161361
[TBL] [Abstract][Full Text] [Related]
14. Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients.
Cohen P; Pagnoux C; Mahr A; Arène JP; Mouthon L; Le Guern V; André MH; Gayraud M; Jayne D; Blöckmans D; Cordier JF; Guillevin L;
Arthritis Rheum; 2007 May; 57(4):686-93. PubMed ID: 17471546
[TBL] [Abstract][Full Text] [Related]
15. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis.
Kluger N; Pagnoux C; Guillevin L; Francès C;
Br J Dermatol; 2008 Sep; 159(3):615-20. PubMed ID: 18647311
[TBL] [Abstract][Full Text] [Related]
19. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
Pagnoux C; Quéméneur T; Ninet J; Diot E; Kyndt X; de Wazières B; Reny JL; Puéchal X; le Berruyer PY; Lidove O; Vanhille P; Godmer P; Fain O; Blockmans D; Bienvenu B; Rollot F; Aït el Ghaz-Poignant S; Mahr A; Cohen P; Mouthon L; Perrodeau E; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2015 Apr; 67(4):1117-27. PubMed ID: 25693055
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
